KINGSLEY R CHIN MD MBA: Founder, Chairman & CEO of KIC | KICVENTURES GROUP
Dr. Kingsley R Chin MBA
American investor, inventor, entrepreneur, engineer, orthopedic spine surgeon, professor, leader, motivator, author, artiste, athlete, philanthropist. He is the Founder, Chairman and CEO of Kingsley Investment Company (KIC) and its venture arm, KICVentures Group, focused on investing to advance health technologies to treat patients worldwide.
“You will change the world when you accept and learn to harness what is different about you, think different, see different, build a team of different people relentless to create something different and prepare to be treated different” - Dr. Kingsley R Chin
I am passionate inventing innovative medical devices to treat patients.
I became fascinated with the human body in high school. This later led to my many patented inventions to replace the spine anatomy such as facet and disc replacements. Growing up in rural Jamaica I enjoyed visiting the local hospital and meeting the doctors. That was until I had a knee injury in soccer causing a painful anterior cruciate ligament tear. We could not afford an orthopedic surgeon. I rehabbed myself back the next year to lead the team in goals to the national Dacosta Cup soccer finals and represented Jamaica as a striker in international competition.
Today I am a board-certified and practicing orthopedic spine surgeon and founder and CEO of KICVentures Group a health technology investment holding company. I get to develop devices with engineers and treat patients in the USA and Jamaica. Life comes full circle for me to empathize and set trends.
My past shaped my future. I grew up poor and fatherless in Buff Bay Jamaica, to a teenage mother. I learned and excelled at our local Titchfield High School before earning an academic-athletic scholarship to the USA. I thank principal Mr. Lloyd O Chin who took me into his home at 15 years old to mentor me and gave me the needed $47 USD (the Jamaican government allowed a maximum $50) on my journey to the USA. I enrolled at Columbia College ranked #1 in Division One Soccer. I thrived and built leadership skills. I earned Ivy League Player of the Year honor and was elected the first Black President of a Student Government in an Ivy League Senior Class. Years later I graduated with honors from Harvard Medical School, distinction from Harvard Orthopedic Residency and Harvard Business School's Executive Program in Leadership Development and completed a Masters in Business Administration.
I love to compete. I read and watch documentaries to study successful people to find clues. I am guided by the vision to solve problems. We built and sold the MANTIS to Stryker for 100x ROI to fill a need. Used the cash to kickstart our growth in value $1B+ with $250M+ in revenues and years of profitable EBITDA.
Dr. Kingsley R Chin with his sons Kingston & Blaze
I value work experience. Mine begun at AT&T Bell Labs as an engineer and Andersen Consulting as an Experienced Management Information System Consultant (Cigna and Goldman Sachs). I spent four years as an Assistant Professor and Chief of Spine Surgery at the University of Pennsylvania. Over 20 years researching and inventing spine innovations and techniques; authoring several books, publishing 90+ peer-reviewed scientific papers, 40+ issued patents, 35+ FDA cleared devices, performing 1000's of spine surgeries and building many diverse companies.
I prioritize health to be here for my family and to lead our companies to execute our vision to be a leader in advancing health technologies to treat patients worldwide. I hope to exemplify leadership excellence to mentor youths and honor past leaders.
About KICVentures Group
Investing in healthcare since 2000, makes KICVentures an experienced healthtech investment holding company focused on spine surgery. We partner with key physicians to identify niche problems affecting patients then acquire or invent differentiated technology solutions with our capital and partner with co-investors. An example is the MANTIS device for minimally invasive screw fixation acquired by Stryker as a 100X return on investment.
Our vision is to lead in healthtech. We own $1 Billion+ in assets and generated $250+ million in revenues. With years of EBITDA profitability, offset from buyout acquisitions such as AxioMed and NanoFuse, we target profitability from exits in Q4 2021 - 2022, IPOs by 2023 and FDA clearance of the AxioMed disc in 2021.